After utilizing immunohistochemistry to evaluate G9a expression in DLBCL tissue sections, we employed the HistoQuest software for a quantitative analysis and observed a statistically significant increase in the number of G9a-positive cells with cancer stage progression. Here, EHMT2 is linked to diffuse large B-cell lymphoma.